Project Grant SB1EY037120
Award Date
5/1/25
Completion Date
4/30/26
Dollars Obligated
$746K
Federal Agency
National Eye Institute
Awardee
Retivue LLC (HKJ8UAHR73M3)
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Virginia, USA
Similar Awards
The National Eye Institute (NEI) awarded a $350,000 Project Grant (CFDA 93.867 - Vision Research) to Retivue LLC in Charlottesville, VA. The grant will support the development of the "EntireEyeScope", a high-resolution, 3D stereo endoscopic viewing system for vitreoretinal surgery. This novel technology aims to provide surgeons with a traditional "top-down" view of the retina, even in cases where the anterior segment is obscured, by using miniature cameras inserted through...
The National Eye Institute (NEI), through its Vision Research program (CFDA 93.867), awarded a $881,796 Project Grant to Siloam Vision, Inc. to develop two advanced, laser-based, artificial intelligence (AI)-enabled retinal imaging systems. The primary goal is to address the unmet need for cost-effective and less stressful methods to diagnose and monitor retinopathy of prematurity (ROP), a leading cause of childhood blindness. The key innovations include: 1) A wider field-of-view camera design...
The National Eye Institute (NEI) awarded a $580,331 Project Grant (CFDA 93.867 - Vision Research) to The Trustees of the Stevens Institute of Technology in Hoboken, New Jersey. The grant funding will support the development of a deep learning-based diagnostic model for retinopathy of prematurity (ROP), a leading cause of childhood blindness globally. The key objectives are to: Optimize and test an animal-to-human (A2H) model using existing retinal image datasets to augment the training data...
The National Eye Institute (NEI) awarded a Project Grant under CFDA 93.867 - Vision Research to Tufts Medical Center Parent, Inc. in Boston, Massachusetts. The $462,072 grant, effective April 1, 2025 through March 31, 2030, will support research on the metabolic basis of retinopathy of prematurity (ROP) and potential treatment with anaplerotic substrates. The project aims to study fatty acid metabolic exchanges between the liver and retina at the systems level, and use anaplerotic substrates...
The National Eye Institute (NEI), part of the National Institutes of Health, awarded a $331,131 Project Grant under the Vision Research program (CFDA 93.867) to Physical Sciences Inc. (PSI) to develop and validate a high-resolution retinal imaging system with light flicker capabilities. This system aims to enable objective characterization of the photoreceptor response to light and quantify differences between normal and diseased eyes, particularly for patients with diabetic retinopathy. PSI,...
This Project Grant awarded by the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) funds the development and evaluation of novel surrogate augmented deep predictive learning algorithms to predict referral-warranted retinopathy of prematurity (RW-ROP). The primary goals are to: Develop algorithms that leverage early retinal images and demographic factors to accurately predict RW-ROP, enabling earlier identification of high-risk infants for close monitoring and...
This $193,168 Project Grant award from the National Eye Institute (CFDA 93.867 Vision Research) to Duke University aims to develop a novel, auto-aligning hand-held optical coherence tomography (OCT) and OCT angiography (OCTA) probe for high-quality pediatric retinal imaging. The funding will support research to combine Duke's expertise in hand-held OCT/A probe development with optical fast-steering components to create a system capable of stable and repeatable retinal structure and...
This $306,462 Project Grant awarded by the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867) will fund the development of a software platform called OCT-ART-DR. The platform will automate the diagnosis and staging of diabetic retinopathy (DR), a leading cause of blindness, using optical coherence tomography angiography (OCTA) imaging and artificial intelligence (AI). The key products to be delivered include: 1) Improved AI-based segmentation of OCTA image...
This Project Grant award from the National Eye Institute (NEI), under the agency's Vision Research program (CFDA 93.867), aims to advance the state of the art in ophthalmic imaging to improve diagnosis and treatment of diabetic retinopathy (DR). The $204,305 award, spanning June 2024 to December 2026, supports the development of two key technologies: An adapted robotically-aligned optical coherence tomography (RAOCT) system that can provide automated, volumetric imaging and measurement of the...
The National Eye Institute (NEI), under the Federal Grant Program "Vision Research" (CFDA 93.867), awarded a $179,440 Project Grant (R21EY037104) to Kennesaw State University to develop a smartphone-based retinal imaging system for early detection of diabetic retinopathy in low- and middle-income countries, with a focus on Egypt. The project aims to create a portable, cost-effective retinal imaging device that can be attached to smartphones, enabling provider-performed retinal...